Herein, we aimed to prepare core cross-linked micelles, which targeted HER2-positive breast cancer cells, with pH-sensitivity features, and compare targeting efficiencies of an HER2-specific peptide (LTVSPWY) and Herceptin antibody towards breast cancer cells. This evidence concerns the gene ERBB2 and breast carcinoma.